EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Commentary: Treating Diseases from Alzheimer’s to Parkinson’s Using Transcranial Pulse Stimulation: Mechanistic Insights, Recent Evidence, and Ethical Considerations

Lars Wojtecki iD

NeuroSci · 17.06.2025 · 6 (2) · 56

DOI: 10.3390/neurosci6020056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroSci, online erschienen am 17.06.2025. Verfasst von Lars Wojtecki. Beteiligte Einrichtung: Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcranial pulse stimulation (TPS) is a non-invasive neuromodulation method that uses, high-intensity acoustic shockwaves to deliver focused mechanical stimulation to neural tissue with minimal thermal effects. The mechanism of action includes but is not limited to promotion of blood flow and angiogenesis through mechanotransduction. Clinical data to date are limited and preliminary. In Alzheimer’s disease (AD), TPS has demonstrated cognitive and mood improvements in pilot studies and secondary endpoint analysis in first randomized trials. The enhancement of gamma-band oscillations and network connectivity has been reported. Clinical observations in Parkinson’s disease (PD) suggest TPS as a hypothesis-generating approach to address non-motor symptoms—such as depression, cognitive decline, and the freezing of gait—through theoretical modulation of basal ganglia–cortical circuits. TPS is CE-marked in Europe for AD and shows a favorable safety profile; however, ethical considerations arise from the limited evidence base, potential impairment of patient autonomy and judgment in dementia, and the risk of withholding established treatments. TPS should only be offered under structured scientific protocols or within patient registries to ensure rigorous oversight. Ensuring that consent processes account for cognitive capacity, and that TPS is applied as adjunct rather than replacement therapy, is paramount. Future research must include large-scale randomized controlled trials (RCTs), standardize stimulation protocols, deepen mechanistic insight, and embed robust ethical frameworks.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseaseethicsmechanotransductionneuromodulationrandomized controlled trialstranscranial pulse stimulation

Autor:innen und Institutionen

  • Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
  • Department of Neurology and Neurorehabilitation, Hospital Zum Heiligen Geist, Academic Teaching Hospital of the Heinrich-Heine-University Düsseldorf, 47906 Kempen, Germany.

ORCID-Profile: Lars Wojtecki

Zitieren

APA

Wojtecki, L. (2025). Commentary: Treating Diseases from Alzheimer’s to Parkinson’s Using Transcranial Pulse Stimulation: Mechanistic Insights, Recent Evidence, and Ethical Considerations. NeuroSci, 6(2), 56. https://doi.org/10.3390/neurosci6020056

Vancouver

Wojtecki L. Commentary: Treating Diseases from Alzheimer’s to Parkinson’s Using Transcranial Pulse Stimulation: Mechanistic Insights, Recent Evidence, and Ethical Considerations. NeuroSci. 2025;6(2):56. doi:10.3390/neurosci6020056

BibTeX
@article{Wojtecki2025,
  author = {Wojtecki, Lars},
  title = {Commentary: Treating Diseases from Alzheimer’s to Parkinson’s Using Transcranial Pulse Stimulation: Mechanistic Insights, Recent Evidence, and Ethical Considerations},
  journal = {NeuroSci},
  year = {2025},
  volume = {6},
  number = {2},
  pages = {56},
  doi = {10.3390/neurosci6020056}
}
Kostenlos starten →